5 Must-Read Analyst Questions From Fortive’s Q2 Earnings Call

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

FTV Cover Image

Fortive’s second quarter saw key operational achievements, but the market responded negatively, with shares declining significantly after results. Management highlighted robust organic growth, especially from new product introductions at Fluke and expanded AI-enabled offerings across software brands. CEO Olumide Soroye emphasized that “our accelerating innovation velocity again translated into faster growth,” noting strong recurring revenue performance and progress in high-growth verticals such as data centers and healthcare. Despite these gains, product mix and regional headwinds, particularly in EMEA, weighed on margins.

Is now the time to buy FTV? Find out in our full research report (it’s free for active Edge members).

Fortive (FTV) Q2 CY2026 Highlights:

  • Revenue: $1.10 billion vs analyst estimates of $1.07 billion (7.9% year-on-year growth, 2.5% beat)
  • Adjusted EPS: $0.74 vs analyst estimates of $0.71 (4.9% beat)
  • Adjusted EBITDA: $323.1 million vs analyst estimates of $316.1 million (29.5% margin, 2.2% beat)
  • Management raised its full-year Adjusted EPS guidance to $3 at the midpoint, a 1.7% increase
  • Operating Margin: 19.1%, up from 16.7% in the same quarter last year
  • Market Capitalization: $18.28 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Fortive’s Q2 Earnings Call

  • Scott Davis (Melius Research) asked how new product introductions tangibly impact revenue. CEO Olumide Soroye confirmed that innovation has been a key driver of recent growth, with rigorous tracking of product performance across brands.
  • Nigel Coe (Wolfe Research) pressed for details on margin headwinds and tax rate outlook. CFO Mark Okerstrom explained that product mix, especially growth in lower-margin lines, and strategic investments are influencing margins, while tax rates are expected in the mid-teens for the year.
  • Deane Dray (RBC Capital Markets) inquired about the progress and returns of AI-enabled software features. Soroye detailed the early, positive customer adoption and cited the long-term head start from Fortive’s AI Center of Excellence.
  • Andy Kaplowitz (Citi) questioned trends in healthcare capital equipment and consumables. Soroye noted a return to growth in capital equipment as hospital budgets stabilize, with strong consumables demand across regions.
  • Chris Snyder (Morgan Stanley) sought clarity on margin expectations for the second half. Okerstrom outlined that margin pressures are driven by mix shifts and increased growth investments, but expects improvement in Q4 as seasonal dynamics normalize.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will be monitoring (1) the pace of adoption and revenue contribution from new AI-enabled software features across key brands, (2) stabilization and potential growth in healthcare capital equipment sales as hospital budgets recover, and (3) execution of targeted bolt-on acquisitions to strengthen core hardware and software platforms. Progress on recurring revenue initiatives and successful integration of recent acquisitions will also be important indicators of execution.

Fortive currently trades at $60.64, down from $64.09 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article